Simon Rodney

1.1k total citations
26 papers, 434 citations indexed

About

Simon Rodney is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Simon Rodney has authored 26 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Simon Rodney's work include Bladder and Urothelial Cancer Treatments (7 papers), Genital Health and Disease (6 papers) and Cervical Cancer and HPV Research (4 papers). Simon Rodney is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Genital Health and Disease (6 papers) and Cervical Cancer and HPV Research (4 papers). Simon Rodney collaborates with scholars based in United Kingdom, United States and Australia. Simon Rodney's co-authors include John D. Kelly, Wei Shen Tan, Benjamin W. Lamb, Mark Feneley, Andrew Feber, Manit Arya, Pramit Khetrapal, Avihu Boneh, Marisa Chau and Asıf Muneer and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and PLoS ONE.

In The Last Decade

Simon Rodney

24 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Rodney United Kingdom 10 298 104 72 70 68 26 434
Stephan Degener Germany 10 164 0.6× 78 0.8× 68 0.9× 73 1.0× 100 1.5× 38 333
Kimio Takai Japan 11 156 0.5× 40 0.4× 99 1.4× 56 0.8× 59 0.9× 37 424
Masuo Yamashita Japan 11 121 0.4× 104 1.0× 78 1.1× 25 0.4× 159 2.3× 26 309
J.F. Jiménez Cruz Spain 9 106 0.4× 78 0.8× 37 0.5× 50 0.7× 124 1.8× 75 289
Pramit Khetrapal United Kingdom 12 337 1.1× 167 1.6× 25 0.3× 59 0.8× 105 1.5× 26 450
F. Sofras Greece 12 100 0.3× 30 0.3× 36 0.5× 39 0.6× 152 2.2× 26 293
Resnick Mi United States 12 215 0.7× 93 0.9× 28 0.4× 56 0.8× 164 2.4× 46 445
Octavian Drăgoescu Romania 5 334 1.1× 95 0.9× 100 1.4× 33 0.5× 73 1.1× 7 439
Mireille Grégoire Canada 9 186 0.6× 234 2.3× 96 1.3× 52 0.7× 69 1.0× 16 431
Hyun Kyu Ahn South Korea 11 106 0.4× 31 0.3× 25 0.3× 83 1.2× 181 2.7× 34 378

Countries citing papers authored by Simon Rodney

Since Specialization
Citations

This map shows the geographic impact of Simon Rodney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Rodney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Rodney more than expected).

Fields of papers citing papers by Simon Rodney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Rodney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Rodney. The network helps show where Simon Rodney may publish in the future.

Co-authorship network of co-authors of Simon Rodney

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Rodney. A scholar is included among the top collaborators of Simon Rodney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Rodney. Simon Rodney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodney, Simon & Udai Banerji. (2023). Optimizing the FDA’s Project Optimus: opportunities and challenges. Nature Reviews Clinical Oncology. 21(3). 165–166. 6 indexed citations
2.
Banerji, Udai, Simon Pacey, Simon Rodney, et al.. (2023). Abstract B044: Results of a phase 1 dose escalation clinical trial of NXP800, a novel GCN2 activator, in patients with advanced or metastatic solid tumors. Molecular Cancer Therapeutics. 22(12_Supplement). B044–B044. 1 indexed citations
3.
Tanić, Miljana, Ismail Moghul, Simon Rodney, et al.. (2022). Comparison and imputation-aided integration of five commercial platforms for targeted DNA methylome analysis. Nature Biotechnology. 40(10). 1478–1487. 6 indexed citations
4.
Rodney, Simon, Charlotte Abson, Russell Burcombe, R. Jyothirmayi, & Catherine Harper‐Wynne. (2021). Abstract PS14-06: Changes in management of breast cancer patients during first wave of COVID19, throughout the area of Kent, United Kingdom. An audit of ESMO guideline implementation. Cancer Research. 81(4_Supplement). PS14–6. 1 indexed citations
5.
Tan, Wei Shen, Rachael Sarpong, Pramit Khetrapal, et al.. (2018). Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?. The Journal of Urology. 200(5). 973–980. 56 indexed citations
6.
Tan, Wei Shen, Rachael Sarpong, Pramit Khetrapal, et al.. (2018). Does urinary cytology have a role in haematuria investigations?. British Journal of Urology. 123(1). 74–81. 24 indexed citations
7.
Khetrapal, Pramit, Wei Shen Tan, Simon Rodney, et al.. (2018). Using plasma cell-free DNA mutations to monitor patients for micro-metastatic bladder cancer after radical cystectomy. European Urology Supplements. 17(2). e1527–e1527.
8.
9.
Feber, Andrew, Ankur Chakravarthy, Patricia de Winter, et al.. (2016). CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma. Cancer Research. 76(16). 4720–4727. 45 indexed citations
11.
Tan, Wei Shen, Simon Rodney, Benjamin W. Lamb, Mark Feneley, & John D. Kelly. (2016). Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia. Cancer Treatment Reviews. 47. 22–31. 73 indexed citations
13.
Tan, Wei Shen, Benjamin W. Lamb, Pramit Khetrapal, et al.. (2016). Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy. Journal of Endourology. 31(2). 141–148. 9 indexed citations
14.
Rodney, Simon & Asıf Muneer. (2016). HPV and Penile Cancer: Perspectives on the Future Management of HPV-Positive Disease.. PubMed. 30(3). 250–2. 2 indexed citations
15.
Feber, Andrew, Rita Nigam, Wei Shen Tan, et al.. (2015). 702 Epigenomics of penile squamous cell carcinoma. European Urology Supplements. 14(2). e702–e702a. 1 indexed citations
16.
Feber, Andrew, Manit Arya, Patricia de Winter, et al.. (2014). Epigenetics Markers of Metastasis and HPV-Induced Tumorigenesis in Penile Cancer. Clinical Cancer Research. 21(5). 1196–1206. 43 indexed citations
17.
Rodney, Simon, Taimur T. Shah, Hitendra Patel, & Manit Arya. (2014). Key papers in prostate cancer. Expert Review of Anticancer Therapy. 14(11). 1379–1384. 7 indexed citations
18.
Rodney, Simon & Avihu Boneh. (2012). Amino Acid Profiles in Patients with Urea Cycle Disorders at Admission to Hospital due to Metabolic Decompensation. JIMD Reports. 9. 97–104. 25 indexed citations
19.
Koizia, Louis, et al.. (2011). The experiences of cancer patients. QJM. 104(12). 1075–1081. 26 indexed citations
20.
Rodney, Simon & Sara Imarisio. (2010). Developing a transgenic marker to research Huntington’s disease in Drosophila melanogaster. International journal of collaborative research on internal medicine & public health. 2(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026